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General Experimental Details 
 
Starting materials sourced from commercial suppliers were used as received unless 
otherwise stated. All reagents requiring purification were purified using standard 
laboratory techniques according to methods published by Perrin, Armarego, and Perrin 
(Pergamon Press, 1966). Catalytic reactions were run under an atmosphere of dry 
nitrogen or argon; glassware, syringes and needles were either flame dried immediately 
prior to use or placed in an oven (200 °C) for at least 2 h and allowed to cool either in a 
desiccator or under an atmosphere of nitrogen or argon; liquid reagents, solutions or 
solvents were added via syringe through rubber septa; solid reagents were added inside 
a glovebox. All optimization reactions were filtered through a sinter funnel charged 
with a pad of celite and silica for copper removal. Coupling partners for Stille reactions 
were distilled before use. Anhydrous solvents were obtained by distillation using 
standard procedures or by passage through drying columns supplied by Anhydrous 
Engineering Ltd. Anhydrous dichloromethane (CH2Cl2) was purged with argon for 10 
minutes prior use. Flash column chromatography (FCC) was performed using silica gel 
(Aldrich 40-63 µm, 230-400 mesh). Thin layer chromatography (TLC) was performed 
using aluminium backed 60 F254 silica plates. Visualization was achieved by UV 
fluorescence or a basic KMnO4 solution and heat. Proton nuclear magnetic resonance 
spectra (NMR) were recorded using either a Varian 400 MHz, Varian 500 MHz or 
Bruker AVANCE DRX400 MHz. 13C NMR spectra were recorded at 100 MHz or 125 
MHz as stated. Chemical shifts (δ) are given in parts per million (ppm). Peaks are 
described as singlets (s), doublets (d), double doublets (dd), triplets (t), double triplets 
(dt), and multiplets (m). 1H and 13C NMR spectra were referenced to the appropriate 
residual solvent peak. Coupling constants (J) are quoted to the nearest 0.5 Hz. All 
assignments of NMR spectra were based on 2D NMR data (DEPT-135, COSY, HSQC 
and HMBC). In situ yields were determined by employing 1,4-dinitrobenzene as an 
internal standard. Mass spectra were recorded using a Brüker Daltonics FT-ICRMS 
Apex 4e 7.0T FT-MS (ESI+ mode) and Shimadzu GCMS QP2010+ (EI+ mode). 
Infrared spectra were recorded on a Perkin Elmer Spectrum One FTIR spectrometer as 
thin films or solids compressed on a diamond plate. Melting points were determined 
using Stuart SMP30 melting point apparatus and are uncorrected. 
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Synthesis of Substrates and Known Compounds: 
 
All commercially available benzoquinones and further commercial chemicals were 
purchased from Sigma Aldrich, Alfa Aesar, Strem Chemicals and Santa Cruz 
Biotechnology. [RhCp*Cl2]2 and [RhCp
tCl2]2 were purchased from Sigma Aldrich. 
[RhCptCl2]2, [RhCp
CF3Cl2]2 and [RhCp
i-PrCl2]2 were synthesised via literature 
procedures already described by our research group.1 
 
2-Methoxy-1,4-benzoquinone (1b) 
 
 
Compound 1b was synthesized (267.9 mg, 97% yield) as a yellow powder using a 
previously reported procedure.3 m.p. (°C) = 133.8-134.1 (Petrol/CH2Cl2); HRMS (EI+): 
138.0311 [M]+. Cald. for [C7H6O3]: 138.0317; 1H NMR (400 MHz, CDCl3) δ: 6.69 (s, 
2H), 5.92 (s, 1H), 3.81 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 187.4, 181.7, 158.6, 
137.2, 134.4, 107.7, 56.2. Data are consistent with those reported in the literature.3 
 
2,3-Dimethyl-1,4-benzoquinone (1c) 
 
 
Compound 1c was synthesised (1.68 g, 90% yield) as yellow crystals using previously 
reported procedures.2,3 m.p. (°C) = 54.9-56.4 (Petrol/CH2Cl2); HRMS (EI+): 136.0569 
[M]+. Cald. for [C8H8O2]: 136.0524; 1H NMR (400 MHz, CDCl3) δ: 6.70 (s, 2H), 2.01 
(s, 6H); 13C NMR (100 MHz, CDCl3) δ: 187.4, 141.0, 136.2, 12.2. Data are consistent 
with those reported in the literature.3  
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2,3-Dichloro-1,4-benzoquinone (1f) 
 
 
 
Compound 1f was synthesised (1.79 g, 60% yield) as yellow crystals using previously 
reported procedure.4 m.p. (°C) = 102.9-103.7 (Petrol/CH2Cl2); HRMS (EI+): 175.9421 
[M]+. Cald. for [C6H2Cl2O2]: 175.9432; 1H NMR (400 MHz, CDCl3) δ: 6.97 (s, 2H); 
13C NMR (100 MHz, CDCl3) δ: 177.4, 141.2, 136.1. Data are consistent with those 
reported in the literature.4 
 
General procedure for halogenation/selenylation at the 2-position: 
 
 
 
In a glovebox, an oven dried re-sealable tube was charged with the corresponding 
benzoquinone (0.10 mmol), [RhCptCl2]2 (3.75 mol%, 2.6 mg), silver 
bis(trifluoromethanesulfonyl)imide (20 mol%, 7.8 mg), the electrophile source (see 
below) and anhydrous copper sulfate (220 mol%, 0.22 mmol, 34.9 mg). The tube was 
removed from the glovebox and an inert atmosphere was maintained. Anhydrous 
CH2Cl2 (1 mL) was added via syringe and tube was sealed. The mixture was heated at 
100 °C for 18h. After cooling, the mixture was filtered through a pad of celite and 
purified by FCC, under the conditions noted. 
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2-Iodo-1,4-benzoquinone (2a) 
 
 
 
The product was obtained by the general procedure described above using 1,3-diiodo-
5,5-dimethylhydantoin (DIH) (150 mol %, 0.12 mmol, 56.9 mg) and a reaction time of 
18 h. Purification by FCC (toluene) afforded product 2a (22 mg, 95% yield) as orange 
crystals; m.p. (°C) = 58.3-58.9 (Petrol/CH2Cl2); IR (solid, cm-1) ν: 3042 (w), 1644 (s), 
1269 (s), 914 (s); HRMS (EI+): 233.9174 [M]+. Cald. for [C6H3IO2]: 233.9178; 
Elemental analysis – Calculated (%) C: 30.80 H: 1.29. Found (%) C: 31.01  H: 
1.30;  1H NMR (400 MHz, CDCl3) δ: 7.67 (d, J = 2.4 Hz, C3-H), 7.00 (d, J = 10.0 Hz, 
C6-H), 6.84 (dd, J = 10.1, 2.4 Hz, C5-H); 13C NMR (100 MHz, CDCl3) δ: 184.0 (C4), 
180.2 (C1), 146.1 (C3), 136.6 (C5), 134.56 (C6), 119.6 (C2). Data are consistent with 
those reported in the literature.5 
 
Figure 1: Crystal structure of compound 2a. 
 
2-Iodo-3-methoxy-1,4-benzoquinone (2b) 
 
 
 
The product was obtained by the general procedure described above using 1,3-diiodo-
5,5-dimethylhydantoin (DIH) (120 mol%, 0.12 mmol, 45.5 mg) and a reaction time of 
18 h. Purification by FCC (toluene) afforded product 2b (24.0 mg, 91% yield) as orange 
crystals; m.p. (°C) = 98.1-99.9 (Petrol/CH2Cl2); IR (solid, cm-1) ν: 3027 (w), 1698 (s), 
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1354 (s), 991 (s); HRMS (EI+): 261.9493 [M]+. Cald. for [C7H5IO3]: 263.9283; 
Elemental analysis – Calculated (%) C: 31.85 H: 1.91. Found (%) C: 32.10  H: 
1.93; 1H NMR (400 MHz, CDCl3) δ: 6.91 (d, J = 10.0 Hz, C6-H), 6.67 (d, J = 10.0 
Hz, C5-H), 4.21 (s, C7-H3); 13C NMR (100 MHz, CDCl3) δ: 181.73 (C1), 179.36 (C4), 
161.43 (C3), 135.10 (C6), 134.66 (C5), 100.93 (C2), 61.67 (C7). 
 
 
Figure 2: Crystal structure of compound 2b. 
 
2-Iodo-5,6-dimethyl-1,4-benzoquinone (2c) 
 
 
 
The product was obtained by the general procedure described above using 1,3-diiodo-
5,5-dimethylhydantoin (DIH) (150 mol%, 0.15 mmol, 56.9 mg) and a reaction time of 
18 h. Purification by FCC (toluene) afforded product 2c (21.2 mg, 81% yield) as a red 
oil; IR (solid, cm-1) ν: 2921 (w), 1638 (s), 1236 (s), 838 (s); HRMS (EI+): 261.9493 
[M]+. Cald. for [C8H7IO2]: 261.9491; 1H NMR (400 MHz, CDCl3) δ: 7.60 (s, C3-H), 
2.11 (d, J = 1.2 Hz, C8-H3), 2.03 (d, J = 1.2 Hz, C7-H3); 13C NMR (100 MHz, CDCl3) 
δ: 184.4 (C4), 180.4 (C1) 146.0 (C3), 141.4 (C5), 140.0 (C6), 119.0 (C2), 13.7 (C8), 
12.4 (C7). The structural assignment of the product was supported by HMBC analysis, 
as indicated above. 
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2-Iodo-6-methyl-1,4-benzoquinone (2da) and 2-Iodo-5-methyl-1,4-benzoquinone 
(2db) 
 
 
 
The product was obtained by the general procedure described above using 1,3-diiodo-
5,5-dimethylhydantoin (DIH) (150 mol%, 0.15 mmol, 56.9 mg) and a reaction time of 
18 h. Purification by FCC (toluene) afforded products 2da and 2db (mixture of isomers, 
5:4/a:b) (20 mg, 81% yield) as an orange powder; HRMS (EI+): 247.9326 [M]+. Cald. 
for [C7H5IO2]: 247.9334; 1H NMR (500 MHz, CDCl3) δ: 7.64 (d, J = 1.4 Hz, C3b-H), 
7.59 (dd, J = 2.4, 1.5 Hz, C3a-H), 6.84 (t, J = 1.6 Hz, C6b-H), 6.66 (dt, J = 2.4, 1.5 Hz, 
C5a-H), 2.14 (t, J = 1.5 Hz, C7a-H3), 2.07 (t, J = 1.5 Hz, C7b-H3); 13C NMR (125 
MHz, CDCl3) δ: 184.6 (C4b), 184.5 (C4a), 180.8 (C1a), 180.4 (C1b), 146.4 (C5b), 
146.2 (C3a), 146.1 (C3b), 144.6 (C6a), 133.5 (C5a), 131.4 (C6b), 119.7 (C2-Ib), 119.3 
(C2-Ia), 17.3 (C7a), 15.8 (C7b). The structural assignments of the products were 
supported by HMBC analysis, as indicated above. 
 
2-Iodo-5-(tert-butyl)-1,4-benzoquinone (2e) 
 
 
 
The product was obtained by the general procedure described above using 1,3-diiodo-
5,5-dimethylhydantoin (DIH) (120 mol%, 0.12 mmol, 45.5 mg) and a reaction time of 
18 h. Purification by FCC (toluene) afforded product 2e (19.2 mg, 66% yield) as a deep 
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yellow solid; m.p. (°C) = 70.5-71.0 (Petrol/CH2Cl2); IR (solid, cm-1) ν: 2960 (s), 1651 
(s), 1180 (s), 1009 (s); HRMS (EI+): 289.9798 [M]+. Cald. for [C10H11IO2]: 289.9804; 
Elemental analysis – Calculated (%) C: 41.40 H: 3.82. Found (%) C: 41.69  H: 
3.85; 1H NMR (400 MHz, CDCl3) δ: 7.54 (s, C3-H), 6.81 (s, C6-H), 1.27 (s, C8-H9); 
13C NMR (100 MHz, CDCl3) δ: 184.2 (C4), 181.3 (C1), 156.6 (C5), 147.9 (C3), 129.8 
(C6), 117.5 (C2), 35.5 (C7), 29.0 (C8). The structural assignment of the product was 
supported by HMBC analysis, as indicated above. 
 
2-Iodo-6-(tert-butyl)-1,4-benzoquinone (2e’) 
 
 
 
Continued elution afforded product 2e’ (5.2 mg, 18% yield) as a deep yellow solid; 
m.p. (°C) = 71.8-72.9 (Petrol/CH2Cl2); IR (solid, cm-1) ν: 2965 (s), 1689 (s), 1218 (s), 
1124 (s); HRMS (EI+): 289.9807 [M]+. Cald. for [C10H11IO2]: 289.9804; 1H NMR (400 
MHz, CDCl3) δ: 7.59 (d, J = 2.4 Hz, C3-H), 6.65 (d, J = 2.4 Hz, C5-H), 1.28 (s, C8-
H9); 13C NMR (100 MHz, CDCl3) δ: 185.3 (C4), 179.9 (C1), 155.1 (C6), 145.1 (C3), 
131.9 (C5), 122.7 (C2), 36.2 (C7), 29.1 (C8). The structural assignment of the product 
was supported by HMBC analysis, as indicated above. 
 
2-Iodo-5,6-dichloro-1,4-benzoquinone (2f) 
 
 
The product was obtained by the general procedure described above using 1,3-diiodo-
5,5-dimethylhydantoin (DIH) (150 mol%, 0.15 mmol, 56.9 mg) and a reaction time of 
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18 h. Purification by FCC (toluene) afforded product 2f (16.9 mg, 56% yield) as yellow 
crystals; m.p. (°C) = 162.8-163.5 (Petrol/CH2Cl2); IR (solid, cm-1) ν: 2973 (w), 1667 
(s), 1046 (m), 881 (s); HRMS (EI+): 301.8402 [M]+. Cald. for [C6HICl2O2]: 301.8398; 
Elemental analysis – Calculated (%) C: 23.79 H: 0.33. Found (%) C: 23.98  H: 
0.33; 1H NMR (400 MHz, CDCl3) δ: 7.83 (s, C3-H); 13C NMR (100 MHz, CDCl3) δ: 
175.3 (C4), 171.9 (C1), 145.2 (C3), 141.6 (C5), 138.2 (C6), 117.4 (C2). The structural 
assignment of the product was supported by HMBC analysis, as indicated above. 
 
2-Bromo-1,4-benzoquinone (3a) 
 
 
 
The product was obtained by the general procedure described above using 1,3-dibromo-
5,5-dimethylhydantoin (DBH) (120 mol%, 0.12 mmol, 34.3 mg) and a reaction time of 
18 h. Purification by FCC (toluene) afforded product 3a (15.3 mg, 82% yield) as yellow 
crystals; m.p. (°C) = 54.5-55.1 (Petrol/CH2Cl2); IR (solid, cm-1) ν: 3042 (w), 1661 (s), 
1276 (s), 967 (s); HRMS (EI+): 185.9312 [M]+. Cald. for [C6H3BrO2]: 185.9316; 
Elemental analysis – Calculated (%) C: 38.54 H: 1.62. Found (%) C: 38.77  H: 
1.63; 1H NMR (400 MHz, CDCl3) δ: 7.29 (d, J = 2.4 Hz, C3-H), 6.96 (d, J = 10.1 Hz, 
C6-H), 6.82 (dd, J = 10.1, 2.4 Hz, C5-H); 13C NMR (100 MHz, CDCl3) δ: 184.55 
(C4), 179.17 (C1), 138.12 (C3), 137.50 (C2), 136.63 (C5), 135.79 (C6). Data are 
consistent with those reported in the literature.6 The structural assignment of the product 
was supported by HMBC analysis, as indicated above. 
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2-Bromo-3-methoxy-1,4-benzoquinone (3b) 
 
 
 
The product was obtained by the general procedure described above using 1,3-dibromo-
5,5-dimethylhydantoin (DBH) (120 mol%, 0.12 mmol, 34.3 mg) and a reaction time of 
18 h. Purification by FCC (toluene) afforded product 3b (16.1 mg, 74% yield) as an 
orange powder; m.p. (°C) = 85.7-86.3 (Petrol/CH2Cl2); IR (solid, cm-1) ν: 2960 (w), 
1651 (s), 1555 (s), 1092 (s); HRMS (EI+): 215.9410 [M]+. Cald. for [C7H5BrO3]: 
215.9422; Elemental analysis – Calculated (%) C: 38.74 H: 2.32. Found (%) C: 
39.09  H: 2.34; 1H NMR (400 MHz, CDCl3) δ: 6.87 (d, J = 10.0 Hz, C6-H), 6.68 (d, J 
= 10.1 Hz, C5-H), 4.21 (s, C7-H3); 13C NMR (100 MHz, CDCl3) δ: 180.8 (C4), 180.3 
(C1), 157.0 (C3), 135.8 (C6), 134.6 (C5), 118.5 (C2), 61.6 (C7). The structural 
assignment of the product was supported by HMBC analysis, as indicated above. 
 
2-Bromo-3-methyl-1,4-benzoquinone (3d) 
 
 
 
The product was obtained by the general procedure described above using 1,3-dibromo-
5,5-dimethylhydantoin (DBH) (120 mol%, 0.12 mmol, 34.3 mg) and a reaction time of 
18 h. Purification by FCC (toluene) afforded product 3d (13.7 mg, 68% yield) as a 
yellow powder; m.p. (°C) = 55.1-56.7 (Petrol/CH2Cl2); IR (solid, cm-1) ν: 2987 (w), 
1596 (s), 1233 (s), 870 (s); HRMS (EI+): 199.9461 [M]+. Cald. for [C7H5BrO2]: 
199.9473; Elemental analysis – Calculated (%) C: 41.83 H: 2.51. Found (%) C: 
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41.74  H: 2.66; 1H NMR (400 MHz, CDCl3) δ: 6.92 (d, J = 10.0 Hz, C6-H), 6.81 (d, J 
= 10.0 Hz, C5-H), 2.23 (s, C7-H3); 13C NMR (100 MHz, CDCl3) δ: 183.9 (C4), 179.1 
(C1), 146.2 (C3), 136.3 (C5), 136.1 (C2), 135.8 (C6), 16.9 (C7). The structural 
assignment of the product was supported by HMBC analysis, as indicated above. 
 
2-Bromo-5-(tert-butyl)-1,4-benzoquinone (3e) 
 
 
 
The product was obtained by the general procedure described above using 1,3-dibromo-
5,5-dimethylhydantoin (DBH) (120 mol%, 0.12 mmol, 34.3 mg) and a reaction time of 
18 h. Purification by FCC (toluene) afforded product 3e (13.9 mg, 57% yield) as a 
yellow powder; m.p. (°C) = 100.2-101.1 (Petrol/CH2Cl2); IR (solid, cm-1) ν: 2963 (s), 
1654 (s), 1013 (s), 733 (s); HRMS (EI+): 241.9932 [M]+. Cald. for [C10H11BrO2]: 
241.9942; Elemental analysis – Calculated (%) C: 49.39 H: 4.56. Found (%) C: 
49.39  H: 4.44; 1H NMR (400 MHz, CDCl3) δ: 7.19 (s, C3-H), 6.78 (s, C6-H), 1.28 (s, 
C8 -H9); 13C NMR (100 MHz, CDCl3) δ: 184.7 (C4), 180.4 (C1), 156.7 (C5), 139.9 
(C3), 135.7 (C2), 130.9 (C6), 35.5 (C7), 29.1 (C8). The structural assignment of the 
product was supported by HMBC analysis, as indicated above. Minor traces of 
regioisomer 3e’ (10:1 3e:3e’), where bromination had occurred at C3, were detected, 
but, due to the low quantities of material formed, good quality NMR data could not be 
obtained. Assignment was made by comparison to 2e’: 1H NMR (500 MHz, CDCl3) δ: 
7.43 (d, J = 2.2 Hz, 1H), 6.54 (d, J = 2.2 Hz, 1H), 1.26 (s, 9H).   
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2-Bromo-5,6-dichloro-1,4-benzoquinone (3f) 
 
 
 
The product was obtained by the general procedure described above using 1,3-dibromo-
5,5-dimethylhydantoin (DBH) (120 mol%, 0.12 mmol, 34.3 mg) and a reaction time of 
18 h. Purification by FCC (toluene) afforded product 3f (11.5 mg, 45% yield) as yellow 
crystals; m.p. (°C) = 153.9-155.1 (Petrol/CH2Cl2); IR (solid, cm-1) ν: 2970 (w), 1671 
(s), 1187 (m), 1052 (s); HRMS (EI+): 253.8542 [M]+. Cald. for [C6HBrCl2O2]: 
253.8537; Elemental analysis – Calculated (%) C: 28.16 H: 0.39. Found (%) C: 
28.30  H: 0.39; 1H NMR (400 MHz, CDCl3) δ: 7.46 (s, C3-H); 13C NMR (100 MHz, 
CDCl3) δ: 175.3 (C4), 171.0 (C1), 141.4 (C5), 140.1 (C6), 137.4 (C3), 136.6 (C2). The 
structural assignment of the product was supported by HMBC analysis, as indicated 
above. 
2-(Phenylselanyl)-1,4-benzoquinone (4a) 
 
 
 
The product was obtained by the general procedure described above using N-phenyl 
selenium phthalimide (100 mol%, 0.1 mmol, 30.2 mg) and a reaction time of 18 h. 
Purification by FCC (toluene) afforded product 4b (16.0 mg, 61% yield) as a red 
powder; m.p. (°C) = 100.4-101.1 (Petrol/CH2Cl2); IR (solid, cm-1) ν: 2921 (w), 1631 
(s), 1279 (m), 967 (s); HRMS (EI+): 263.9682 [M]+. Cald. for [C12H8SeO2]: 263.9690; 
Elemental analysis – Calculated (%) C: 54.77 H: 3.06. Found (%) C: 54.99  H: 
3.07; 1H NMR (400 MHz, CDCl3) δ: 7.64-7.53 (m, C8-H, C12-H), 7.53-7.39 (m, C9-
H, C10-H, C11-H), 6.85 (d, J = 10.0 Hz, C6-H), 6.68 (dd, J = 10.0, 2.4 Hz, C5-H), 6.15 
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(d, J = 2.4 Hz, C3-H); 13C NMR (100 MHz, CDCl3) δ: 184.8 (C1), 184.1 (C4), 154.5 
(C2), 137.5 (C5), 137.0 (C8), 135.9 (C6), 130.5 (C3), 130.4 (C9), 130.2 (C10), 123.9 
(C7). The structural assignment of the product was supported by HMBC analysis, as 
indicated above. Compound 4a’ was eluted first and obtained (5.4 mg, 13% yield) as an 
orange powder. The data for this compound are given at the end of the next procedure.  
 
2,5-Bis(phenylselanyl)-1,4-benzoquinone (4a’) 
 
 
The product was obtained by the general procedure described above using N-phenyl 
selenium phthalimide (250 mol%, 0.25 mmol, 75.5 mg) and a reaction time of 18 h. 
Purification by FCC (toluene) afforded product 4a (30.9 mg, 74% yield) as an orange 
powder; m.p. (°C) = 230.3-231.0 (Petrol/CH2Cl2); IR (solid, cm-1) ν: 3055 (w), 1634 
(s), 1546 (m), 990 (s); HRMS (ESI+): 420.9263 [M+H]+. Cald. for [C18H13Se2O2]: 
420.9244; Elemental analysis – Calculated (%) C: 51.70 H: 2.89. Found (%) C: 
52.11  H: 2.91; 1H NMR (400 MHz, CDCl3) δ: 7.63-7.53 (m, C8-H), 7.54-7.39 (m, 
C9-H, C10-H), 6.21 (s, C3-H, C6-H); 13C NMR (100 MHz, CDCl3) δ: 181.38 (C1, 
C4), 157.1 (C2, C5), 136.9 (C8), 130.4 (C9), 130.2 (C10), 129.4 (C3, C6), 124.1 (C7). 
The structural assignment of the product was supported by HMBC analysis, as 
indicated above. 
 
2,3-Dimethyl-5-(phenylselanyl)-1,4-benzoquinone (4c) 
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The product was obtained by the general procedure described above using N-phenyl 
selenium phthalimide (120 mol%, 0.12 mmol, 36.2 mg) and a reaction time of 18 h. 
Purification by FCC (toluene) afforded product 4c (21.3 mg, 73% yield) as red crystals; 
m.p. (°C) = 98.1-99.0 (Petrol/CH2Cl2); IR (solid, cm-1) ν: 2930 (w), 1634 (s), 1236 
(m), 746 (s); HRMS (EI+): 292.0006 [M]+. Cald. for [C14H12SeO2]: 292.0003; 
Elemental analysis – Calculated (%) C: 57.74 H: 4.15. Found (%) C: 58.17  H: 
4.18; 1H NMR (500 MHz, CDCl3) δ: 7.62-7.54 (m, C8-H), 7.51-7.37 (m, C9-H, C10-
H), 6.11 (s, C3-H), 2.06 (s, C13-H3), 1.99 (s, C14-H3); 13C NMR (125 MHz, CDCl3) δ: 
184.9 (C1), 184.2 (C4), 153.6 (C2), 141.9 (C6), 140.5 (C5), 137.0 (C8), 130.5 (C3), 
130.2 (C9), 129.9 (C10), 124.5 (C7), 12.4 (C13, C14). The structural assignment of the 
product was supported by HMBC analysis, as indicated above. 
 
5-(tert-Butyl)-2-(phenylselanyl)-1,4-benzoquinone (4ea) and 6-(tert-butyl)-2-
(phenylselanyl)-1,4-benzoquinone (4eb)  
 
 
 
The product was obtained by the general procedure described above using N-phenyl 
selenium phthalimide (120 mol %, 0.12 mmol, 36.2 mg) and a reaction time of 18h.  
Purification by FCC (toluene) afforded products 4ea and 4eb (mixture of isomers, 
5:2/a:b) (19.5 mg, 61% yield) as a red oil; HRMS (EI+): 321.0405 [M+H]+. Cald. for 
[C16H17O2Se]: 321.0393; 1H NMR (400 MHz, CDCl3) δ: 7.65 - 7.58 (m, 5H), 7.52 – 
7.41 (m, 5H), 6.69 (s, C3a-H), 6.52 (d, J = 2.4 Hz C3b-H), 6.11 (d, J = 2.4 Hz, C6b-H), 
6.07 (s, C6a-H), 1.32 (s, C8b-H9), 1.27 (s, C8a-H9); 13C NMR (125 MHz, CDCl3) δ: 
185.7 (C1a), 185.0 (C4b), 184.8 (C1b), 184.3 (C4a), 157.2 (C5a), 155.8 (C6a) 152.0 
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(C6b), 137.0 (C11a, C12a, C13a), 132.6 (C3a), 132.5 (C3b), 130.9 (C10b, C14b), 130.3 
(C11b, C12b, C13b, C9a), 130.1 (C9b) 130.0 (C10a, C14a), 129.7 (C5b), 124.7 (C2b), 
124.1 (C2a), 35.4 (C7a,C7b), 29.3 (C8a), 29.2 (C8b). The structural assignment of the 
product was supported by HMBC analysis, as indicated above. 
 
2-(Phenylselanyl)-1,4-naphthoquinone (6) 
 
 
 
The product was obtained by the general procedure described above using N-phenyl 
selenium phthalimide (120 mol%, 0.12 mmol, 36.2 mg) and a reaction time of 18 h. 
Purification by FCC (toluene) afforded product 6 (26.9 mg, 86% yield) as orange 
crystals; m.p. (°C) = 152.8-153.7 (Petrol/CH2Cl2); IR (solid, cm-1) ν: 2930 (w), 1664 
(s), 1296 (m), 690 (s); HRMS (EI+): 313.9848 [M]+. Cald. for [C16H10SeO2]: 313.9846; 
Elemental analysis – Calculated (%) C: 61.36 H: 3.22. Found (%) C: 61.43  H: 
3.56; 1H NMR (400 MHz, CDCl3) δ: 8.14 (dd, J = 7.2, 1.9 Hz, C8-H), 8.03 (dd, J = 
6.1, 1.9 Hz, C5-H), 7.82-7.67 (m, C6-H, C7-H), 7.68-7.61 (m, C10-H), 7.57-7.42 (m, 
C11-H, C12-H), 6.40 (s, C3-H); 13C NMR (100 MHz, CDCl3) δ: 183.0 (C1), 181.7 
(C4), 157.0 (C2), 137.1 (C10), 134.3 (C6), 133.3 (C7), 132.8 (C3), 132.3 (C4a), 131.6 
(C8a), 130.4 (C11), 130.2 (C12), 126.9 (C8), 126.7 (C5), 124.4 (C9). Data are 
consistent with those reported in the literature.7  
 
Figure 3: Crystal structure of compound 6. 
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2-Phenoxy-1,4-benzoquinone (7a) 
 
 
 
Product 7a was synthesised using a previously reported procedure.8 A 5 mL reaction 
tube was charged with 2a (0.10 mmol, 23.4 mg) or 3a (0.1 mmol, 18.7 mg), phenol 
(0.11 mmol, 10.3 mg), KF (0.3 mmol, 17.4 mg) and DMF (1 mL). The mixture was 
stirred and heated at 90 °C for 1h. After cooling and solvent removal, the mixture was 
purified by FCC (toluene) to afford 7a (16.2 mg, 81% yield from 2a, 15.8 mg, 79% 
yield from 3a) as a yellow solid; m.p. (°C) = 133.8-134.1 (Petrol/CH2Cl2); HRMS 
(EI+): 200.0468 [M]+. Cald. for [C12H8O3]: 200.0473; 1H NMR (400 MHz, CDCl3) δ: 
7.49-7.39 (m, 2H), 7.35-7.28 (m, 1H), 7.14-7.05 (m, 2H), 6.81 (d, J = 10.1 Hz, 1H), 
6.72 (dd, J = 10.1, 2.3 Hz, 1H), 5.73 (d, J = 2.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) 
δ: 187.5, 181.5, 158.6, 152.3, 137.0, 137.0, 134.5, 130.4, 126.7, 120.9, 111.0. Data are 
consistent with those reported in the literature.9 
 
2-Phenylamino-1,4-benzoquinone (7b) 
 
 
Compound 7b was synthesised using a previously reported procedure.10 A 5 mL 
reaction tube was charged with 2a (0.10 mmol, 23.4 mg), aniline (0.12 mmol, 11.2 µL) 
and H2O (0.5 mL). The mixture was stirred for 1h. The precipitate was collected by 
filtration and purified by FCC (toluene) to afford 7b (19.1 mg, 96% yield) as a dark 
yellow powder; m.p. (°C) = 131.5-133.4 (Petrol/CH2Cl2); MS (EI+): 199.1 [M]
+. Cald. 
for [C12H9NO2]: 199.1; 1H NMR (400 MHz, CDCl3) δ: 8.14 (s, 1H), 7.10-6.95 (m, 
4H), 6.63-6.51 (m, 4H); 13C NMR (100 MHz, CDCl3) δ: 184.9, 181.6, 159.0, 158.5, 
146.5, 138.4, 129.8, 128.6, 127.0, 123.0. Data are consistent with those reported in the 
literature.11 
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2-Phenyl-1,4-benzoquinone (7c) 
 
 
 
Compound 7c was synthesised using a previously reported procedure.1 A oven dried re-
sealable tube was charged with 2a (0.10 mmol, 23.4 mg), Pd(dtbpf)Cl2 (5 mol %, 3.7 
mg), CuI (20 mol %, 4.0 mg) and CsF (0.20 mmol, 30.0 mg). The tube was purged with 
N2 and PhSnBu3 (0.12 mmol, 40.0 µL) and N,N-dimethylacetamide (1 mL) were added 
via syringe. The tube was sealed and the mixture was heated at 45 °C for 18h. After 
cooling, the solvent was removed under reduced pressure. The residue was dissolved in 
CH2Cl2 (5 mL) and filtered through a pad of celite. The filtrate was concentrated under 
reduced pressure and the residue was purified by FCC (hexane/EtOAc 5:1) to afford 7c 
(13.1 mg, 71% yield) as an golden powder; m.p. (°C) = 108.8-110.0 (Petrol/CH2Cl2); 
HRMS (EI+): 184.0511 [M]+. Cald. for [C12H8O2]: 184.0524; 1H NMR (400 MHz, 
CDCl3) δ: 7.52-7.39 (m, 5H), 6.92-6.79 (m, 3H); 13C NMR (100 MHz, CDCl3) δ: 
187.6, 186.6, 145.9, 137.0, 136.2, 132.7, 130.1, 129.2, 128.5. Data are consistent with 
those reported in the literature.12 
 
2-(4-fluorophenyl)-1,4-benzoquinone (7d) 
 
 
Compound 7d was synthesised using a previously reported procedure13 with small 
modifications. A oven dried re-sealable tube was charged with 2a (0.10 mmol, 23.4 
mg), Pd(dtbpf)Cl2 (5 mol %, 3.7 mg), Na2CO3 (200 mol %, 21.2 mg) and (4-
fluorophenyl)boronic acid (0.11 mmol, 15.4 mg). The tube was purged with N2 and 
N,N-dimethylacetamide (1 mL) were added via syringe. The tube was sealed and the 
mixture was heated at 50 °C for 14h. After cooling, the solvent was removed under 
reduced pressure. The residue was dissolved in CH2Cl2 (5 mL) and filtered through a 
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pad of celite. The filtrate was concentrated under reduced pressure and the residue was 
purified by FCC (toluene) to afford 7d (11.1 mg, 55% yield) as an golden powder; m.p. 
(°C) = 149.8-152.2 (Petrol/CH2Cl2); MS (EI+): 202.0 [M]
+. Cald. for [C12H7FO2]: 
202.0; 1H NMR (400 MHz, CDCl3) δ: 7.48-7.51 (m, 2H), 7.12-7.14 (m, 2H), 6.80-6.89 
(m, 3H); 13C NMR (100 MHz, CDCl3) δ: 187.6, 186.8, 165.2, 144.7, 136.9, 136.7, 
132.7, 131.2 (d, J = 8.2 Hz), 129.5, 115.6 (d, J = 21.6 Hz). Data are consistent with 
those reported in the literature.14 
 
Intermolecular competition experiment between 1a and d4-1a 
 
 
A competition experiment involving the iodination of equimolar quantities of 1a and 
deuterio-1a was conducted. At 30% conversion, a 1.6;1 ratio of 2a to d3-2a was 
obtained as determined by 1H/2H NMR analysis against a 1:1 mixture of 1a and d4-1a. 
This result confirms that C-H cleavage is kinetically significant, but does not elucidate 
whether or not this is the rate determining step. 
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Figure 4: 1H NMR spectra (400 MHz, CDCl3) and 
2H NMR spectra (400 MHz, CHCl3) 
for determination of the 2a/d3-2a ratio. A 1:1 ratio of benzoquinone:d4-benzoquinone 
was used as a standard. 
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Figure 4: 1H NMR spectrum (400 MHz, CDCl3) of compound 2a. 
 
 
 
Figure 5: 13C NMR spectrum (100 MHz, CDCl3) of compound 2a. 
S21 
 
 
Figure 6: 1H NMR spectrum (400 MHz, CDCl3) of compound 2b. 
 
 
 
Figure 7: 13C NMR spectrum (100 MHz, CDCl3) of compound 2b. 
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Figure 8: 1H NMR spectrum (400 MHz, CDCl3) of compound 2c. 
 
 
 
Figure 9: 13C NMR spectrum (100 MHz, CDCl3) of compound 2c. 
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Figure 10: 1H NMR spectrum (500 MHz, CDCl3) of compound 2d. 
 
 
 
Figure 11: 13C NMR spectrum (125 MHz, CDCl3) of compound 2d. 
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Figure 12: 1H NMR spectrum (400 MHz, CDCl3) of compound 2e. 
 
 
 
Figure 13: 13C NMR spectrum (100 MHz, CDCl3) of compound 2e. 
S25 
 
 
Figure 14: 1H NMR spectrum (400 MHz, CDCl3) of compound 2e’. 
 
 
 
Figure 15: 13C NMR spectrum (100 MHz, CDCl3) of compound 2e’. 
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Figure 16: 1H NMR spectrum (400 MHz, CDCl3) of compound 2f. 
 
 
 
Figure 17: 13C NMR spectrum (100 MHz, CDCl3) of compound 2f. 
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Figure 18: 1H NMR spectrum (400 MHz, CDCl3) of compound 3a. 
 
 
 
Figure 19: 13C NMR spectrum (100 MHz, CDCl3) of compound 3a. 
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Figure 20: 1H NMR spectrum (400 MHz, CDCl3) of compound 3b. 
 
 
 
Figure 21: 13C NMR spectrum (100 MHz, CDCl3) of compound 3b. 
S29 
 
 
Figure 22: 1H NMR spectrum (400 MHz, CDCl3) of compound 3d. 
 
 
 
Figure 23: 13C NMR spectrum (100 MHz, CDCl3) of compound 3d. 
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Figure 24: 1H NMR spectrum (400 MHz, CDCl3) of compound 3e. 
 
 
 
Figure 25: 13C NMR spectrum (100 MHz, CDCl3) of compound 3e. 
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Figure 26: 1H NMR spectrum (400 MHz, CDCl3) of compound 3f. 
 
 
 
Figure 27: 13C NMR spectrum (100 MHz, CDCl3) of compound 3f. 
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Figure 28: 1H NMR spectrum (400 MHz, CDCl3) of compound 4a’. 
 
 
 
Figure 29: 13C NMR spectrum (100 MHz, CDCl3) of compound 4a’. 
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Figure 30: 1H NMR spectrum (400 MHz, CDCl3) of compound 4a. 
 
 
 
Figure 31: 13C NMR spectrum (100 MHz, CDCl3) of compound 4a. 
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Figure 32: 1H NMR spectrum (500 MHz, CDCl3) of compound 4c. 
 
 
 
Figure 33: 13C NMR spectrum (125 MHz, CDCl3) of compound 4c. 
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Figure 34: 1H NMR spectrum (400 MHz, CDCl3) of compound 4e. 
 
 
 
Figure 35: 13C NMR spectrum (100 MHz, CDCl3) of compound 4e. 
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Figure 36: 1H NMR spectrum (400 MHz, CDCl3) of compound 6. 
 
 
 
Figure 37: 13C NMR spectrum (100 MHz, CDCl3) of compound 6. 
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